Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00687739 · ClinicalTrials.gov registry record · Phase 3
Prevention of Obesity in Women Via Estradiol Regulation
A Phase 3 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 3
- Development phase
- 79
- Enrollment target
NCT00687739 is a Phase 3 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 79 participants.
The verdict
NCT00687739, a Phase 3 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 79 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate potential mechanisms by which estradiol deficiency accelerates fat gain and abdominal fat accumulation in women.
Interventions
- DRUG leuprolide acetate
- DRUG Estradiol Transdermal
- BEHAVIORAL progressive resistance exercise training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2008-05 |
| Est. Completion | 2014-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00687739
The ClinicalTrials.gov registry entry for NCT00687739 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which leuprolide acetate is the first listed.
NCT00687739 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00687739 about?
NCT00687739 is a clinical study titled "Prevention of Obesity in Women Via Estradiol Regulation". The purpose of this study is to evaluate potential mechanisms by which estradiol deficiency accelerates fat gain and abdominal fat accumulation in women.
What is the current status of trial NCT00687739?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 79 participants. The study started on 2008-05. Estimated completion is 2014-06.
What interventions are being tested in trial NCT00687739?
The interventions under investigation include: leuprolide acetate (DRUG), Estradiol Transdermal (DRUG), progressive resistance exercise training (BEHAVIORAL).
Who is sponsoring clinical trial NCT00687739?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.